Trutino Biosciences
San Diego
About Trutino Biosciences
Trutino Biosciences is a biopharmaceutical company that develops the next generation of cytokine therapies. Trutino’s proprietary On-Demand-Cytokine (ODC) platform technology enables the design of therapeutic candidates that can be systemically delivered in an inactive cytokine form and be locally activated directly at the tumor site, thereby avoiding the extreme toxicity of conventional cytokine therapies, and potentially improving efficacy either as a single agent or in combination with other treatment modalities. The company was founded in 2017 and is based in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Non-Equity Assistance (Jan 2021)
- Website: trutinobio.com#
- Phone: 858-880-5501
Industries & Categories
Biopharma, Biotechnology, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/trutino-biosciences-2702050 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.